Home › Funds › Michael J. Porro & Co. Financial Advisors, Inc. › VRTX

Michael J. Porro & Co. Financial Advisors, Inc. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Michael J. Porro & Co. Financial Advisors, Inc. reported holding 4,364 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 1.38% of its reported portfolio and ranking #22 among its reported holdings. Michael J. Porro & Co. Financial Advisors, Inc. has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)4.36K sh
Reported value held$2.28M
Portfolio Weight1.38%
First reportedQ4 2025
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Michael J. Porro & Co. Financial Advisors, Inc.'s VRTX position evolved

Michael J. Porro & Co. Financial Advisors, Inc. first disclosed a stake in VRTX in Q4 2025 at 3,818 shares (US$1.7M). The position peaked in Q3 2026 at 4,364 shares, worth US$2.3M. Across 4 filings, Michael J. Porro & Co. Financial Advisors, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 4,364 shares valued at US$2.3M — an increase of 561 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.82K $1.73M New
Q1 2026 3.81K $1.70M Hold
Q2 2026 3.80K $1.89M Hold
Q3 2026 4.36K $2.28M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Michael J. Porro & Co. Financial Advisors, Inc. held VRTX?

Michael J. Porro & Co. Financial Advisors, Inc. has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Michael J. Porro & Co. Financial Advisors, Inc.'s current position in VRTX?

As of Q3 2026, Michael J. Porro & Co. Financial Advisors, Inc. holds 4.36K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $2.28M, representing 1.38% of its reported portfolio and ranking #22.

Has Michael J. Porro & Co. Financial Advisors, Inc. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Michael J. Porro & Co. Financial Advisors, Inc. increased its position in VRTX. The position peaked in Q3 2026 at 4.36K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.